The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?
Volume
7
DOI
10.1183/23120541.00768-2020
Journal
ERJ Open Res
Issue
ISSN
2312-0541
Metadata
Show full item recordAbstract
Asthma therapy, including monoclonal antibodies, was not associated with #COVID19 infection or hospitalisation in a UK severe asthma population. Shielding led to a reported worsening of mental health in nearly half of patients contacted (47%). https://bit.ly/3jImUsG.